Qiagen raises FY24 adjusted EPS view to $2.19 from $2.10, consensus $2.15
PremiumThe FlyQiagen raises FY24 adjusted EPS view to $2.19 from $2.10, consensus $2.15
6d ago
Qiagen reports Q3 adjusted EPS 57c, consensus 54c
Premium
The Fly
Qiagen reports Q3 adjusted EPS 57c, consensus 54c
6d ago
Qiagen announces FDA clearance for QIAstat-Dx Meningitis/Encephalitis Panel
Premium
The Fly
Qiagen announces FDA clearance for QIAstat-Dx Meningitis/Encephalitis Panel
9d ago
Neogen appoints Bernard to the board of directors
PremiumThe FlyNeogen appoints Bernard to the board of directors
1M ago
Qiagen gets European  IVDR certification
Premium
The Fly
Qiagen gets European IVDR certification
2M ago
Qiagen, Bode team to advance GEDmatch PRO forensic genealogy database
Premium
The Fly
Qiagen, Bode team to advance GEDmatch PRO forensic genealogy database
2M ago
Qiagen Launches $450 Million Convertible Bond Offering
PremiumCompany AnnouncementsQiagen Launches $450 Million Convertible Bond Offering
2M ago
Qiagen expands QIAstat-Dx into precision medicine
Premium
The Fly
Qiagen expands QIAstat-Dx into precision medicine
3M ago
Qiagen price target raised to EUR 45 from EUR 44 at Morgan Stanley
Premium
The Fly
Qiagen price target raised to EUR 45 from EUR 44 at Morgan Stanley
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100